Following its October $14.6bn recapitalisation of BioMed Realty, the largest private owner of life science office buildings in the United States, Blackstone announced in (...)
As the sizeable transactions carried out in recent months by some of the world’s most prominent institutional players indicate, real estate investor interest for the life sciences sector is rising. Established, well-defined and specialised clusters have emerged in the US as a growing asset class. Still at a very early stage in Europe, it is poised to do the same on our continent.
Following its October $14.6bn recapitalisation of BioMed Realty, the largest private owner of life science office buildings in the United States, Blackstone announced in (...)
Already a subscriber? Login
LONDON
LONDON
NEW YORK
LONDON
LONDON
LONDON
HAAREN
NEW YORK
NEW YORK
CHICAGO
© Business Immo 2024 CoStar Group
